Incyte Corp

Incyte Corp is a leading biopharmaceutical company that is dedicated to discovering, developing, and commercializing innovative medicines. With a mission to improve the lives of patients suffering from serious diseases, Incyte focuses on advancing scientific research and developing new therapies. The company's portfolio includes drugs for the treatment of cancer, inflammation, and autoimmune disorders. Its flagship product, Jakafi, is the first and only FDA-approved treatment for patients with polycythemia vera, a rare blood cancer. Incyte is also developing a pipeline of novel drugs that target key pathways involved in cancer and immune system regulation. The company is committed to advancing science and collaborating with partners to bring new treatments to patients in need.